Trial Profile
Influence of Azilsartan or Olmesartan on renin-angiotensin-aldosterone system.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Mar 2018
Price :
$35
*
At a glance
- Drugs Azilsartan (Primary) ; Olmesartan medoxomil
- Indications Essential hypertension
- Focus Pharmacodynamics
- 26 Mar 2018 Status changed from active, no longer recruiting to completed.
- 28 Jun 2013 New trial record